About the medicine
- Active ingredients
- Golimumab
- INN
- Голимумаб
- Strength
- 45 мг, 50 мг
- Dosage form
- Раствор для подкожного введения
- Manufacturer
- Силаг АГ (Швейцария)
- Dispensing
- Prescription only
- Registration certificate
- РК-ЛС-5№026541, РК-ЛС-5№026542
- Registered
- 31 Mar 2025
- Registration valid until
- 31 Mar 2030
- Shelf life
- 3 год
- ATC code
- L04AB — Tumor necrosis factor alpha (TNF-alpha) inhibitors
- Country of registration
- Kazakhstan
Packs 2
- По 0.5 мл препарата в одноразовой шприц-ручке (SmartJect®). 1 шприц-ручка в пачке из картона.
- По 0.45 мл препарата в одноразовой шприц-ручке (VarioJect®). 1 шприц-ручка в пачке из картона.
Package leaflet
There is no leaflet with these active ingredients in the reference yet. Read the leaflet in the pack and ask a doctor or pharmacist.
Other forms and manufacturers
This is reference information and does not replace a doctor's advice. Do not self-medicate: read the leaflet and ask a specialist before use.
Source: State Register of Medicines of the Republic of Kazakhstan (register.ndda.kz).